See more : Trilogiq S.A. (ALTRI.PA) Income Statement Analysis – Financial Results
Complete financial analysis of Enzolytics Inc. (ENZC) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Enzolytics Inc., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Bright Outdoor Media Limited (BRIGHT.BO) Income Statement Analysis – Financial Results
- StoneBridge Acquisition Corporation (APACW) Income Statement Analysis – Financial Results
- TransUnion (TRU) Income Statement Analysis – Financial Results
- Wharf Real Estate Investment Company Limited (WRFRF) Income Statement Analysis – Financial Results
- Trenchant Capital Corp. (TCC.CN) Income Statement Analysis – Financial Results
Enzolytics Inc. (ENZC)
About Enzolytics Inc.
Enzolytics, Inc., a drug development company, focuses to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. Its patented anti-HIV therapeutics and a proprietary methodology for producing human IgG1 monoclonal antibodies for treating infectious diseases with non-toxic passive immunotherapy. The company has clinically tested anti-HIV therapeutics. In addition, it has created a proprietary cell line that produces human monoclonal antibodies that target and neutralizes the HIV virus. Enzolytics Inc. is based in Plano, Texas.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 52.80K | 0.00 | 200.00K | 0.00 | 0.00 | 5.00K | 190.00K | 0.00 | 0.00 | 36.97K | 14.71K | 5.69K | 0.00 |
| Cost of Revenue | 22.09K | 22.09K | 16.96K | 16.96K | 16.96K | 16.81K | 741.20K | 18.75K | 19.22K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 30.71K | -22.09K | 183.04K | -16.96K | -16.96K | -11.81K | -551.20K | -18.75K | -19.22K | 36.97K | 14.71K | 5.69K | 0.00 |
| Gross Profit Ratio | 58.16% | 0.00% | 91.52% | 0.00% | 0.00% | -236.20% | -290.10% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% | 0.00% |
| Research & Development | 171.61K | 567.87K | 116.75K | 501.81K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.90M | 936.82K | 394.12K | 40.20K |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 2.01M | 2.31M | 1.47M | 2.78M | 645.41K | 1.69M | 264.81K | 45.29K | 5.02M | 2.90M | 936.82K | 394.12K | 40.20K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.29M | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 2.18M | 2.88M | 1.59M | 3.29M | 645.41K | 1.69M | 264.81K | 45.29K | 5.02M | 2.91M | 950.12K | 403.00K | 43.18K |
| Cost & Expenses | 2.20M | 2.90M | 1.61M | 3.30M | 662.37K | 1.71M | 1.01M | 64.04K | 5.04M | 2.91M | 950.12K | 403.00K | 43.18K |
| Interest Income | 2.00 | 60.00 | 91.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 27.72K | 37.32K | 37.33K | 177.30K | 118.82K | 50.99K | 61.73K | 21.92K | 24.62K | 68.95K | 34.38K | 28.64K | 21.64K |
| Depreciation & Amortization | 22.09K | 22.09K | 20.44K | 16.96K | 16.96K | 16.81K | 322.99K | 18.75K | 19.22K | 12.38K | 13.30K | 8.87K | 2.98K |
| EBITDA | -2.12M | -2.88M | -611.72K | -3.29M | 1.06M | -1.69M | 327.44K | -45.29K | -5.02M | -7.43M | -922.12K | -388.44K | 316.60K |
| EBITDA Ratio | -4,019.30% | 0.00% | -695.19% | 0.00% | 0.00% | -33,798.60% | -259.48% | 0.00% | 0.00% | -16,649.25% | -6,269.48% | -6,830.26% | 0.00% |
| Operating Income | -2.15M | -2.90M | -1.41M | -3.30M | -662.37K | -1.71M | -816.01K | -64.04K | -5.04M | -2.88M | -935.41K | -397.31K | -43.18K |
| Operating Income Ratio | -4,070.01% | 0.00% | -705.41% | 0.00% | 0.00% | -34,134.80% | -429.48% | 0.00% | 0.00% | -7,777.15% | -6,359.89% | -6,986.30% | 0.00% |
| Total Other Income/Expenses | -28.03K | -37.26K | 741.33K | -177.30K | 1.58M | -50.99K | 758.73K | -489.33K | -24.62K | -4.64M | -34.38K | -28.64K | -356.80K |
| Income Before Tax | -2.18M | -2.94M | -669.49K | -3.48M | 920.43K | -1.76M | -57.28K | -553.37K | -5.07M | -7.51M | -969.79K | 0.00 | -399.98K |
| Income Before Tax Ratio | -4,123.10% | 0.00% | -334.74% | 0.00% | 0.00% | -35,154.52% | -30.15% | 0.00% | 0.00% | -20,325.46% | -6,593.61% | 0.00% | 0.00% |
| Income Tax Expense | 2.00 | 2.00 | -2.00 | -4.00 | -4.00 | 0.00 | -4.00 | -3.78K | -19.28K | -3.22M | 0.00 | 28.64K | 378.44K |
| Net Income | -2.18M | -2.94M | -669.49K | -3.48M | 920.43K | -1.76M | -57.28K | -549.59K | -5.05M | -7.51M | -969.79K | -425.95K | -421.62K |
| Net Income Ratio | -4,123.10% | 0.00% | -334.74% | 0.00% | 0.00% | -35,154.52% | -30.15% | 0.00% | 0.00% | -20,325.46% | -6,593.61% | -7,489.85% | 0.00% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.04 | -541.66 | -256.63 | -118.91 | -155.29 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | -0.04 | -541.66 | -256.63 | -118.91 | -155.29 |
| Weighted Avg Shares Out | 2.93B | 2.82B | 2.80B | 959.33M | 959.33M | 391.52M | 171.67M | 110.79M | 114.79M | 13.87K | 3.78K | 3.58K | 2.72K |
| Weighted Avg Shares Out (Dil) | 2.93B | 2.82B | 2.80B | 959.33M | 959.33M | 391.52M | 171.67M | 110.79M | 114.79M | 13.87K | 3.78K | 3.58K | 2.72K |
Trending Penny Stocks to Buy Now? 3 Small-Caps to Watch
Best trending penny stocks to watch now? Check these 3 out for your watchlist The post Trending Penny Stocks to Buy Now?
4 Hot Penny Stocks to Watch With High Volume in August
Top high volume penny stocks to watch in August 2021 The post 4 Hot Penny Stocks to Watch With High Volume in August appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Enzolytics Announces the Appointment of Steve Sharabura as President of its Wholly Owned Subsidiary RobustoMed, Inc (A/K/A ENZO SUB)
COLLEGE STATION, TX / ACCESSWIRE / July 26, 2021 / Enzolytics, Inc. (OTC PINK:ENZC) ("Enzolytics" and the "Company") announced today the appointment of Steve Sharabura as President of the Company's wholly owned subsidiary RobustoMed, Inc. (A/K/A ENZO SUB) based in...
These Penny Stocks Are Frequently Talked About on Reddit, Here's Why
Reddit penny stocks are in focus right now; here's 3 to watch The post These Penny Stocks Are Frequently Talked About on Reddit, Here's Why appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Could These Biotech Penny Stocks Explode in August 2021?
Why these biotech penny stocks are seeing heightened momentum right now The post Could These Biotech Penny Stocks Explode in August 2021? appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Enzolytics and Lonza Bioscience Combine Technologies to Fast-track Development and Production of Anti-HIV and Anti-SARS-CoV-2 Monoclonal Antibodies produced by Enzolytics
COLLEGE STATION, TX / ACCESSWIRE / July 21, 2021 / Enzolytics, Inc. (OTC PINK:ENZC) Enzolytics and Lonza Bioscience are combining their respective technologies to fast-track development and production of anti-HIV and anti-SARS-CoV-2 Monoclonal Antibodies produced by Enzolytics. Lonza is a...
Enzolytics Announces the Signing of a Letter of Intent with Creative Biolabs, Inc. for Licensing and Commercialization of anti-HTLV-1 Monoclonal Antibodies
COLLEGE STATION, TX / ACCESSWIRE / July 20, 2021 / Enzolytics, Inc. (OTC PINK:ENZC) ("Enzolytics" and the 'Company') announces the signing of a Letter of Intent (LOI) with Creative Biolabs ("Creative") (https://www.creative-biolabs.com) to complete the joint production and commercialization of...
4 Stocks To Watch With The Stock Market Down Today
Which Penny Stocks Are Investors Watching After the Stock Market Crash? The post 4 Stocks To Watch With The Stock Market Down Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Best Tech Penny Stocks to Buy in 2021? 3 to Watch in July
Which Tech Penny Stocks Are on Your July 2021 Watchlist? The post Best Tech Penny Stocks to Buy in 2021?
Trending Reddit Penny Stocks to Buy Now? Take a Look At These 7
Which Reddit penny stocks are investors watching right now? Check these 7 out The post Trending Reddit Penny Stocks to Buy Now?
Source: https://incomestatements.info
Category: Stock Reports